Kolexia
Pasquier Florence
Hématologie
Gustave-Roussy
Villejuif, France
95 Activités
0 Followers

Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Leucémies Leucémie aigüe myéloïde Leucémie-lymphome lymphoblastique à précurseurs B et T Leucémie myéloïde Syndromes myéloprolifératifs Syndromes myélodysplasiques Myélofibrose primitive Tumeurs hématologiques Thrombocytémie essentielle

Industries

Pfizer
4 collaboration(s)
Dernière en 2023
Abbvie
2 collaboration(s)
Dernière en 2023
Novartis
2 collaboration(s)
Dernière en 2021
Servier
2 collaboration(s)
Dernière en 2023

Dernières activités

Nilotinib with or without cytarabine for Philadelphia positive acute lymphoblastic leukemia.
Blood   07 mars 2024
Deregulation of the p19/CDK4/CDK6 axis in Jak2 megakaryocytes accelerates the development of myelofibrosis.
Leukemia   20 février 2024
Involvement of the JAK-STAT Pathway in the Molecular Landscape of Fusion-Free Myeloid Neoplasms with Eosinophilia
65th ASH Annual Meeting Abstracts   02 novembre 2023
Mutational Profile and Dynamics of PPM1D-Mutant Clones in the Spectrum of Myeloid Disorders
65th ASH Annual Meeting Abstracts   02 novembre 2023
Frontline Consolidation with Nelarabine for Adults with High-Risk T-Cell Acute Lymphoblastic Leukemia. Results of the Graall-2014/T Atriall Phase 2 Study
65th ASH Annual Meeting Abstracts   02 novembre 2023
1-Year Data Analysis from a Cancer Center Molecular Tumor Board Dedicated to Clonal Hematopoiesis
65th ASH Annual Meeting Abstracts   02 novembre 2023
Exploring the Heterogeneity of Response to Blinatumomab in High-Risk Philadelphia-Negative B-Cell Precursor Acute Lymphoblastic Leukemia: An Analysis from the QUEST Sub-Study of the Graall-2014/B Trial
65th ASH Annual Meeting Abstracts   02 novembre 2023
Oncogenetic-Driven Targeted Therapy for Relapsed/Refractory T-Cell Acute Lymphoblastic Leukemia : A French ALL-Target Observatory Report
65th ASH Annual Meeting Abstracts   02 novembre 2023
CAR T-Cells for the Treatment of B-Cell Acute Lymphoblastic Leukemia.
Journal of clinical medicine   31 octobre 2023
Single-cell multi-omics identifies chronic inflammation as a driver of TP53-mutant leukemic evolution.
Nature genetics   04 septembre 2023